← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA GLOBAL · Approved 2008-04-21

Drug application

FDA Application #
ANDA078805
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRINOTECAN HYDROCHLORIDE
Generic name
Irinotecan Hydrochloride
Active ingredients
IRINOTECAN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
SUN PHARMA GLOBAL
First approval
2008-04-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown